Tracking a Tactile Signal Along the Nervous System
1 other identifier
interventional
60
1 country
1
Brief Summary
Quantify the flow of a tactile signal from the stimulus at the finger at the peripheral nervous system (PNS), to the central nervous system (CNS), and to cognitive perception at the brain in young adults (Aim 1) and individuals with and without stroke (Aim 2).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Feb 2024
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 30, 2024
CompletedStudy Start
First participant enrolled
February 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
November 6, 2025
March 1, 2025
3.3 years
January 8, 2024
November 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Conscious detection threshold
The magnitude at which a force stimulus applied to the finger can be first consciously detected. Different force levels will be applied, and the participant will indicate which of these forces can be detected. The changes in force applied will be in the units of N.
30 minutes during the first session of a one session protocol
Secondary Outcomes (1)
Brain activation
60 minutes during the first session of a one session protocol
Other Outcomes (1)
Peripheral nerve function
30 minutes during the first session of a one session evaluation protocol
Study Arms (1)
Stimulus magnitude
EXPERIMENTALDiffering levels of tactile stimulus will be applied
Interventions
Tactile stimuli of differing magnitudes will be applied
Eligibility Criteria
You may qualify if:
- right-hand dominance for participants who are neurotypical
- For Aim 1:
- age range of 18-23
- For Aim 2:
- participants who are neurotypical will be a similar age to the participants with stroke
- participants who are neurotypical will have no musculoskeletal and neurological conditions
- participants with stroke will have a single stroke incident resulting in a unilateral lesion (ischemic and hemorrhagic)
- participants with stroke will be in the chronic phase (\>1 year from stroke onset)
- participants with stroke will have an onset of stroke after the age of 18
- participants with stroke who meet the criteria of having the capacity to provide informed consent, regardless of aphasia
You may not qualify if:
- minors
- pregnant women
- prisoners
- adults not capable of consenting on their own behalf.
- For Aim 2:
- participants with stroke who have used antispastic injections in the past six months
- participants with stroke who have a lesion in the brainstem and/or cerebellum
- participants with stroke who have a stroke arising due to brain surgery
- participants with stroke who have hemineglect
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Tech
Blacksburg, Virginia, 24061, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Netta Gurari, PhD
Virginia Polytechnic Institute and State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 30, 2024
Study Start
February 29, 2024
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2028
Last Updated
November 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share